Plasma Neutrophil Gelatinase-Associated Lipocalinin in the General Population | Zendy

Søren Lindberg | Zendy; Jan Svejgaard Jensen | Zendy; Rasmus Møgelvang | Zendy; Sune Pedersen | Zendy; Søren Galatius | Zendy; Allan Flyvbjerg | Zendy; Nils E. Magnusson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Neutrophil Gelatinase-Associated Lipocalinin in the General Population

Author(s) -

Søren Lindberg,

Jan Svejgaard Jensen,

Rasmus Møgelvang,

Sune Pedersen,

Søren Galatius,

Allan Flyvbjerg,

Nils E. Magnusson

Publication year - 2014

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.114.303950

Subject(s) - medicine , lipocalin , myocardial infarction , framingham risk score , population , proportional hazards model , c reactive protein , confounding , acute phase protein , renal function , gastroenterology , inflammation , disease , environmental health

Neutrophil gelatinase-associated lipocalin (NGAL) is a glycoprotein stored in granules of neutrophil leukocytes participating in inflammatory and atherosclerotic processes and possibly plaque rupture. Despite the putative role of NGAL in atherosclerosis and acute myocardial infarction, human studies of plasma NGAL are still limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research